Literature DB >> 8267734

Comment on the Nottingham Prognostic Index.

J Brown, M Jones, E A Benson.   

Abstract

Mesh：

Year:  1993        PMID： 8267734     DOI： 10.1007/bf00689843

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  8 in total

1.  Comparison of Oncotype DX® Recurrence Score® with other risk assessment tools including the Nottingham Prognostic Index in the identification of patients with low-risk invasive breast cancer.

Authors:  Maura Bríd Cotter; Alex Dakin; Aoife Maguire; Janice M Walshe; M John Kennedy; Barbara Dunne; Ciarán Ó Riain; Cecily M Quinn
Journal:  Virchows Arch       Date:  2017-07-14       Impact factor: 4.064

Review 2.  Advancement of prognostic models in breast cancer: a narrative review.

Authors:  Ningning Min; Yufan Wei; Yiqiong Zheng; Xiru Li
Journal:  Gland Surg       Date:  2021-09

3.  Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer.

Authors:  E A Rakha; D Soria; A R Green; C Lemetre; D G Powe; C C Nolan; J M Garibaldi; G Ball; I O Ellis
Journal:  Br J Cancer       Date:  2014-03-11       Impact factor: 7.640

4.  Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series.

Authors:  Andrew R Green; Daniele Soria; Jacqueline Stephen; Desmond G Powe; Christopher C Nolan; Ian Kunkler; Jeremy Thomas; Gillian R Kerr; Wilma Jack; David Cameron; Tammy Piper; Graham R Ball; Jonathan M Garibaldi; Emad A Rakha; John Ms Bartlett; Ian O Ellis
Journal:  J Pathol Clin Res       Date:  2016-01-15

5.  Low Concordance between Gene Expression Signatures in ER Positive HER2 Negative Breast Carcinoma Could Impair Their Clinical Application.

Authors:  Enora Laas; Peter Mallon; Francois P Duhoux; Amina Hamidouche; Roman Rouzier; Fabien Reyal
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

6.  The Performance of the Nottingham Prognosis Index and the Adjuvant Online Decision Making Tool for Prognosis in Early-stage Breast Cancer Patients.

Authors:  Mehri Rejali; Mehdi Tazhibi; Fariborz Mokarian; Nazjamal Gharanjik; Reyhane Mokarian
Journal:  Int J Prev Med       Date:  2015-10-01

7.  Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer.

Authors:  Andrew R Green; D Soria; D G Powe; C C Nolan; M Aleskandarany; M A Szász; A M Tőkés; G R Ball; J M Garibaldi; E A Rakha; J Kulka; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  2016-04-26       Impact factor: 4.872

8.  Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index.

Authors:  Ginette Serrero; Douglas M Hawkins; Pablo A Bejarano; Olga Ioffe; Katherine R Tkaczuk; Robert E Elliott; Jonathan F Head; Jeffrey Phillips; Andrew K Godwin; JoEllen Weaver; David Hicks; Binbin Yue
Journal:  Diagn Pathol       Date:  2016-08-08       Impact factor: 2.644
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.